Skip to content
Research Article Open access CC BY 4.0

An Overview of FDA Approved Liposome Formulations for Cancer Therapy

Khushal Gajera, Adil Patel

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 1–7 · Published 19 Apr 2022

10.9734/jamps/2022/v24i330288

Abstract

One of the early achievements of researchers to develop Nano drug delivery systems were successfully manifested in the form of liposomes. Since the time of its invention in 1965, many technological advancements have been witnessed in Liposomal drug delivery systems, which are a field of study. The capacity to change a drug's biodistribution profile, liposomes have been reported to enhance and improve the therapeutic index of different drugs. Drugs of various categories like antineoplastic, antifungal agents, and Anti-inflammatory agents properties and therapy genes have been extensively studied for efficient delivery using liposomes. US-FDA-approved products like Doxil®, Ambisome®, DepoDur™, etc have been seen to play an important part in the treating of a large number of patients across the world. This review aims to provide updated information about various approved and marketed liposome formulations and their role in the modern-day health care systems.

Liposomes therapeutic applications drug carriers liposome technology nanomaterials clinical studies commercial products

Cited by 14

Surface-modified lipid-based nanocarriers as a pivotal delivery approach for cancer therapy: application and recent advances in targeted cancer treatment‏

Doaa M. Anwar, Heidy Y. Hedeya, Sama H. Ghozlan · Beni-Suef University Journal of Basic and Applied Sciences · 2024

Liposomal nanocarriers in precision oncology: Advances and prospects

Yanhui Li, Wenhu Zhou · Critical Reviews in Oncology/Hematology · 2026

Showing 13 of 14 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

14

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.